NPCIL, a premier Public Sector Enterprise under Department of Atomic Energy, Government of India having comprehensive capability in all facets of Nuclear Technology viz.
Healthy Life Pharma (P) Limited is acknowledged world wide at pharma horizon, providing a broad range of pharmaceutical formulation to cope with the necessity of ailing humanity. With its headquarter at Mumbai (India), Healthy Life Pharma holds expertise in offering different formulations that include injectable, tablets and latest drug delivery systems. Healthy Life Pharma (P) Limited is the flagship company of Shah Group, founded by Mr. Manu Shah in 1976. An encouraging leader and inspiring personality, Mr.
Lyka Labs Limited is committed to creating a better tomorrow for India. Maintaining a core competency in Lyophilization, allows Lyka Labs to supply Freeze Dried Drugs in sufficient quantities with the right quality. Lyka strives to manage this business in an ethical and transparent manner.
Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.
Naprod’s vision is to become a world class player in oncology through excellence in innovation, discovery of new manufacturing processes / drug delivery mechanisms and consistently high quality of production. We commenced operations in 1994 with the inauguration of our ultra-modern facility for the production of generics and formulations for oncology and other therapeutic applications. We are one of the pioneers in India in lyophilization.
Healthy Life Pharma has an excellent state-of-the-art infrastructure unit situated in Tarapur Industrial Area, Mumbai, India. The production plant has WHO-GMP certification for its compliance to international standards of manufacturing. Not only this, but it also meets the cGMP norms, put in the "Revised Schedule M" by the Drug Controller (General) India, Ministry of Health, Government of India.